Ruxolitinib partially reverses functional NK cell deficiency in patients with STAT1 gain-of-function mutations
Published in 2017 by
Alexander Vargas Hernandez,
Emily M. Mace,
Ofer Zimmerman,
Christa S. Zerbe,
Alexandra F. Freeman,
Sergio Rosenzweig,
Jennifer W. Leiding,
Troy Torgerson,
Matthew C. Altman,
Edith Schussler,
Charlotte Cunningham-Rundles,
Ivan K. Chinn 
,
Imelda C. Hanson,
Nicholas L. Rider,
Steven M. Holland
and other authors.
,
Imelda C. Hanson,
Nicholas L. Rider,
Steven M. Holland
and other authors.
